Prothrombin Gene Mutation Thrombophilia

Let's continue our thrombophilia series with prothrombin gene mutation

What is Prothrombin?

Prothrombin, also known as Factor II, is a clotting factor produced by the liver. It's a precursor protein that gets converted to thrombin during the clotting cascade. Thrombin plays a central role in hemostasis by converting fibrinogen to fibrin and helping to stabilize the blood clot.

What is Prothrombin Gene Mutation?

The prothrombin gene mutation (also called prothrombin G20210A or Factor II mutation) is a variant in the prothrombin gene that results in elevated levels of prothrombin in the blood. The mutation is a single nucleotide change (G to A) at position 20210 in the 3' untranslated region of the prothrombin gene. This leads to increased prothrombin production, which in turn increases the risk of clot formation. Like Factor V Leiden, it can be present in heterozygous or homozygous states.

Prevalence:

  • 2-3% of Caucasian population have heterozygous prothrombin gene mutation

  • Homozygous state is rare, occurring in less than 0.01% of the population

  • Less common in Hispanic populations and rare in Asian, African, and Native American populations

  • Second most common inherited thrombophilia after Factor V Leiden

Risk of VTE:

  • Heterozygous prothrombin gene mutation increases the risk of developing VTE by 2 to 5 fold

  • Homozygous prothrombin gene mutation is rare but carries a higher risk, estimated at 10-20 fold increased risk

  • Like Factor V Leiden, additional risk factors are often present when patients develop clots, such as estrogen/testosterone exposure, immobilization, surgery, pregnancy, or malignancy

  • Having prothrombin gene mutation does not significantly increase the risk of arterial thrombosis (heart attacks and strokes)

Fun fact: Patients who are compound heterozygotes (having both Factor V Leiden AND prothrombin gene mutation) have a significantly higher VTE risk than either mutation alone - approximately 20-fold increased risk!

Management:

  • 1st Acute VTE episode: same as initial provoked/unprovoked VTE

  • Recurrent provoked VTE: consider long-term anticoagulation

  • Recurrent unprovoked VTE: likely benefit from long-term anticoagulation

  • Pregnancy: close monitoring with consideration for prophylactic anticoagulation based on personal or strong family history of VTE, particularly in the postpartum period when risk is highest

Overall, the VTE risk with prothrombin gene mutation alone is moderate and does not typically warrant prophylactic anticoagulation in the absence of additional risk factors.

Reference: ASH SAP 8th edition, Poort et al, Blood 1996

I hope you found this helpful! In the next post, we'll continue with other inherited thrombophilias.

Click the subscribe button below to receive more content straight to your inbox!

Meet the Best Alcohol Replacement of the Season

As the nights get colder and holiday gatherings fill the calendar, I’ve been craving a new kind of ritual—something warm, social, and feel-good, without the fogginess that often follows a drink. And this season, I found it.

Meet Vesper, Pique’s brand-new, non-alcoholic adaptogenic aperitif—and truly one of the most exciting launches they’ve ever released. Crafted with rare botanicals and science-backed ingredients, it delivers everything I love about a drink: the unwind, the mood lift, the sense of connection… just without the alcohol.

Each sip brings a soft drop in the shoulders, a gentle lift in spirit, and a clear, grounded presence. Sparkling, tart, and herbaceous, Vesper feels luxurious and intentionally crafted—perfect for holiday parties, cozy nights in, and an elevated start to Dry January.

Because it’s new (and already going viral), it will sell out fast.

I’d love to hear from you! Please reply to this email with your thoughts- do you like it, do you not like it? What would you like to see, what would you’d rather not see? Thank you!

Did you find this useful? What other topic would you like me to simplify in this newsletter? Reply to this email to let me know!

Disclaimer: The content in this newsletter is for educational purposes only and should not be considered medical advice. Subscription to this newsletter does not establish a doctor-patient relationship. Always consult your physician with specific questions regarding your health

Fact-based news without bias awaits. Make 1440 your choice today.

Overwhelmed by biased news? Cut through the clutter and get straight facts with your daily 1440 digest. From politics to sports, join millions who start their day informed.

Keep Reading

No posts found